Search

everythinglearnresearchcommunity

for

Search:↓

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

MicroRNAs may help diagnose and treat hair loss disorders.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Low vitamin D levels are common in people with Alopecia Areata.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

CD2 might be a new treatment target for patchy alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Platelets play a key role in the immune system and their lifespan and aging are important for developing new treatments.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

The first Japanese family with Marie Unna hereditary hypotrichosis showed hair condition improvement in a child and highlighted the risk of misdiagnosis.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.